These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30592544)

  • 1. GAG replenishment therapy for bladder pain syndrome/interstitial cystitis.
    Wyndaele JJJ; Riedl C; Taneja R; Lovász S; Ueda T; Cervigni M
    Neurourol Urodyn; 2019 Feb; 38(2):535-544. PubMed ID: 30592544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans--a review.
    Madersbacher H; van Ophoven A; van Kerrebroeck PE
    Neurourol Urodyn; 2013 Jan; 32(1):9-18. PubMed ID: 22782909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome/interstitial cystitis.
    Gülpınar Ö; Esen B; Kayış A; Gökçe Mİ; Süer E
    Neurourol Urodyn; 2018 Jan; 37(1):257-262. PubMed ID: 28480984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical glycosaminoglycans in the management of chronic cystitis.
    Iacovelli V; Topazio L; Gaziev G; Bove P; Vespasiani G; Finazzi Agrò E
    Minerva Urol Nefrol; 2013 Dec; 65(4):249-62. PubMed ID: 24091478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan nanoplatelets exert an intrinsic anti-inflammatory activity in a rat model of bladder painful syndrome/interstitial cystitis.
    Diaz-Salmeron R; Cailleau C; Denis S; Ponchel G; Bouchemal K
    J Control Release; 2023 Apr; 356():434-447. PubMed ID: 36921722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol of a multicentre double-blind RCT, comparing a traditional RCT with an aggregated N-of-1 trial: GAG therapy Efficacy Trial Solution for Bladder pain syndrome/Interstitial cystitis (GETSBI study).
    van Ginkel C; Baars C; Heesakkers J; Martens F; Janssen D
    BMJ Open; 2023 Apr; 13(4):e068546. PubMed ID: 37045569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ls clinical practice aligned with the latest scientific evidence on GAG therapy?
    Janssen DAW
    Urologia; 2017 Sep; 84(Suppl 1):16-20. PubMed ID: 28862729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial cystitis/bladder pain syndrome and glycosaminoglycans replacement therapy.
    Cervigni M
    Transl Androl Urol; 2015 Dec; 4(6):638-42. PubMed ID: 26816865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).
    Meng E; Hsu YC; Chuang YC
    Low Urin Tract Symptoms; 2018 Jan; 10(1):3-11. PubMed ID: 29341502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome.
    Jensen MM; Jia W; Schults AJ; Isaacson KJ; Steinhauff D; Green B; Zachary B; Cappello J; Ghandehari H; Oottamasathien S
    Biomaterials; 2019 Oct; 217():119293. PubMed ID: 31276948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC).
    Chuang YC; Chermansky C; Kashyap M; Tyagi P
    Expert Opin Investig Drugs; 2016; 25(5):521-9. PubMed ID: 26940379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravesical glycosaminoglycan substitution therapy on bladder pain syndrome/interstitial cystitis, bladder capacity and potassium sensitivity.
    Daha LK; Riedl CR; Lazar D; Simak R; Pflüger H
    Scand J Urol Nephrol; 2008; 42(4):369-72. PubMed ID: 19230170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparative analysis of intravesical sodium hyaluronate monotherapy and its combination with oral chondroitin sulfate in patietns with bladder pain syndrome/intersticial cystitis].
    Aboyan IA; Aboyan VE; Pavlov SV; Zinkovskaya OV; Pavlov DS
    Urologiia; 2019 Apr; (1):35-39. PubMed ID: 31184015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.
    Dellis A; Papatsoris AG
    Expert Opin Investig Drugs; 2014 Jun; 23(6):751-7. PubMed ID: 24749738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Painful bladder syndrome and interstitial cystitis: treatment options.
    Fiander N
    Br J Nurs; 2013 May 9-22; 22(9):S26, S28-33. PubMed ID: 23752572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SuperGAG biopolymers for treatment of excessive bladder permeability.
    Towner RA; Greenwood-Van Meerveld B; Mohammadi E; Saunders D; Smith N; Sant GR; Shain HC; Jozefiak TH; Hurst RE
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00709. PubMed ID: 33540486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol.
    Rahnama'i MS; Marcelissen T; Apostolidis A; Veit-Rubin N; Schurch B; Cardozo L; Dmochowski R
    Neurourol Urodyn; 2018 Jun; 37(S4):S99-S107. PubMed ID: 29363792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.